{
    "nct_id": "NCT06373497",
    "official_title": "IT2023-08-ATKINS-ATHERO-RT: Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography",
    "inclusion_criteria": "Inclusion Criteria\n\n* Age ≥ 18 years.\n* Have clinical stage II-III or oligo-metastatic stage IV malignancy (any histology) planned to be treated with thoracic radiotherapy (≥30 Gy) where the heart is in the treatment field.\n* Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2.\n* Planning to receive standard of care radiotherapy treatment.\n* Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.\n* Ability to read, write, and understand English\n\nExclusion Criteria\n\n* Estimated glomerular filtration rate (eGFR) <45 mL/min/m2 or serum creatinine ≥1.5 mg/dL.\n* Patients with a known or previous allergy to iodinated contrast, gadolinium contrast, and/or 18F-NaF tracer.\n* Inability to receive PET tracer.\n* Inability to receive MRI, requiring sedation for MRI, or prohibitive implant and/or device, including ferromagnetic implants and ferromagnetic foreign bodies.\n* Subjects with claustrophobia, problems being in enclosed spaces, or inability to lie supine.\n* Subjects that are pregnant or breastfeeding.\n* Subjects unable to comply with visit instructions, including inability to lie still, hold breathe, or follow procedure instructions.\n* Allergy to animal dander or animal-instigated asthma.\n* Any other condition which, in the opinion of the investigator, may make the patient a poor candidate for participation in a clinical trial\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}